Search Medical Centers

Leukaemia Stem Cell Therapy Abroad

Hospitals and medical centers performing Stem cell treatment for blood cancer and leukaemia.

Medipol Mega University Hospital

Medipol Mega Hospital Complex is a modern medical facility with four specialist hospitals and an extensive selection of high caliber medical devices available for use. The hospital provides treatments in a wide variety of medical fields in its 470 bed facility.


Leukaemia is treated at Medipol Mega University Hospital

Hospital Quirónsalud Malaga

With more than 36 medical specialties, 200 physicians and surgeons of the highest level, Quironsalud Hospital Malaga is one of the most pertinent hospitals in Spain.


Leukaemia is treated at Hospital Quirónsalud Malaga

Hospital Quirónsalud Barcelona

Quirónsalud Hospital Barcelona is the benchmark for private healthcare in southern Europe, providing world-class service for the past seventy years.


Leukaemia is treated at Hospital Quirónsalud Barcelona

Centro Médico Quironsalud Teknon

One of the leading hospitals in the private health sector in Spain, with its high quality of medical and welfare service in an environment that combines personal attention with the latest technology. IMTJ Best International Hospital of the world (awards 2019


Leukaemia is treated at Centro Médico Quironsalud Teknon

Hospital Quirónsalud Torrevieja

Quironsalud Hospital Torrevieja is an ISO-certified private hospital located in the north of Torrevieja, championing excellence in cancer treatment and management. IMTJ Best International Hospital of the world (awards 2017)


Leukaemia is treated at Hospital Quirónsalud Torrevieja

Hospital Quirónsalud Valencia

Hospital Quirónsalud Valencia is ranked as one of the best private schools in Spain, winning nine times in the TOP 20 award in recognition of its management and quality of care.


Leukaemia is treated at Hospital Quirónsalud Valencia

Grupo Hospitalario Quirónsalud

Quirón has an internationally prestigious medical staff, the largest in the sector, and is also the principal hospital network in terms of patient numbers and care facility area. The group administers 47 healthcare centers, more than 4.000 hospital beds and 8.000 doctors


Leukaemia is treated at Grupo Quirónsalud

Hospital Quirónsalud Marbella

This international hospital incorporates prestigious doctors, invests in research and development, technology and continuing education that enhances skills, in facilities, and in an increased operational efficiency in order to provide nothing but the best


Leukaemia is treated at Hospital Quirónsalud Marbella

Hospital Ruber Internacional

The mission of the Stem Cell Transplantation and Cellular Therapy Department is to utilize transplantation therapies to eliminate cancer and provide personalized patient care.


Leukaemia is treated at Hospital Ruber Internacional


Medicenter treats patients using Cord Blood Stem Cells and Bone Marrow Stem Cells.


Leukaemia is treated at Medicenter

Stem cell therapy centers (Page 1 of 1)

About Leukaemia Stem Cell Therapy

This information is intended for general information only and should not be considered as medical advice on the part of Any decision on medical treatments, after-care or recovery should be done solely upon proper consultation and advice of a qualified physician.

What causes leukemia?

Leukemia is blood cancer that are caused when certain genes undergo a series of rare mutations. In all forms of leukemia, there is an overproduction of white blood cells. They form blasts and the cells cannot perform the normal function which is to protect the body against disease and infection.

Most types of leukemia are thought to undergo several rare mutations for them to develop and the first change is presumed to occur in a cell that remains in the body for a long time. The prime candidate group of cells is called the hematopoietic stem cells (HSCs) which are primitive blood cell precursors.

HSCS make new blood cells inside our bodies for our whole lives and if a genetic change affects a cell, all the cells it produces will inherit the same mutation. However, to develop from HSCs into specialized cells such as the white blood cells, the HSCs have to go through a number of steps.

Risk factors

  • Genetic inheritance
  • Accidental exposure to radiation
  • Treatment with some anti-cancer drugs

How is healthy blood stem cells used to treat leukemia?

Acute leukemia is life threatening and requires immediate treatment which is usually intensive. Treatment options include steroids, chemotherapy and hematopoietic stem cell transplant (HSCT). Sometimes HSCT combines with chemotherapy and followed by a transplant of healthy HSCs.

The cells for the transplant are collected from a healthy donor’s blood or bone marrow. The transplant is effective because the donated cells have immune cells which kill the leukemic cells and HSCs which rescue the production of blood.

In some cases, the patient’s own cells are used for the transplant if enough healthy cells can be collected prior to the treatment being performed.

If a different donor is needed the patient’s tissue must be matched to avoid the transplanted donor cells being rejected and attacked by the patient’s residual immune system.

Before the stem cell transplant, the patient undergoes an intensive treatment to destroy as many leukemia cells as possible. High doses of chemotherapy or radiation therapy are given. In some cases, a mini-allogeneic transplant is given. This involves using lower and less toxic chemotherapy doses before the transplant.

The stem cells are administered intravenously like in a blood transfusion and the procedure takes approximately an hour. The stem cells enter the blood stream and travel to the bone marrow where they begin to make new blood cells in a process called engraftment.

Complications of stem cell treatments to treat leukemia

  • Infections: In the time it takes to produce new blood cells for the body the patient is very vulnerable to infections. The patient has to be under close observation and restricted from other people. Antibiotics are usually used as a preventative e form of treatment
  • Graft-versus-host disease (GvHD): This is a complication that occurs when the patient’s normal tissues are attacked by the donor blood cells. This complication is characterized by symptoms such as blisters, rashes, fever, and diarrhea. GvHD is minimized by matching very closely the donor’s tissue type to the patient’s. Other ways of preventing GvHD include removing lymphocytes from the transplant and using drugs to suppress the immune system.

Learn more about Leukaemia

Copyright © 2008 - 2021, All Rights Reserved